AC Immune (ACIU) Shares Outstanding (Weighted Average) (2016 - 2025)
AC Immune (ACIU) has disclosed Shares Outstanding (Weighted Average) for 10 consecutive years, with $127.3 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 4909.66% to $127.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.3 million through Dec 2025, up 4909.66% year-over-year, with the annual reading at $127.3 million for FY2025, 4909.66% up from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 was $127.3 million at AC Immune, up from $2.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $127.3 million in Q4 2025, with the low at $2.5 million in Q4 2024.
- Average Shares Outstanding (Weighted Average) over 5 years is $81.9 million, with a median of $95.5 million recorded in 2023.
- The sharpest move saw Shares Outstanding (Weighted Average) crashed 97.34% in 2024, then soared 4909.66% in 2025.
- Over 5 years, Shares Outstanding (Weighted Average) stood at $97.3 million in 2021, then decreased by 10.84% to $86.7 million in 2022, then increased by 10.09% to $95.5 million in 2023, then plummeted by 97.34% to $2.5 million in 2024, then skyrocketed by 4909.66% to $127.3 million in 2025.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $127.3 million, $2.5 million, and $95.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.